Palisades Investment Partners’s Ardelyx ARDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,147
Closed -$59.2K 53
2025
Q4
$59.2K Hold
10,147
0.02% 51
2025
Q3
$55.9K Sell
10,147
-511,093
-98% -$2.78M 0.02% 49
2025
Q2
$2.04M Sell
521,240
-2,105
-0.4% -$8.68K 0.89% 33
2025
Q1
$2.57M Buy
523,345
+5,564
+1% +$29.9K 1.29% 29
2024
Q4
$2.63M Buy
517,781
+34,432
+7% +$190K 1.11% 32
2024
Q3
$3.33M Buy
483,349
+30,778
+7% +$182K 1.45% 23
2024
Q2
$3.35M Buy
+452,571
New +$3.18M 1.66% 22

Other funds holding ARDX

Palisades Investment Partners's ARDX Position: Q1 2026 in Review

Palisades Investment Partners sold out of Ardelyx (ARDX) in Q1 2026, closing a stake of 10,147 shares — an estimated $59.2K sold.

Palisades Investment Partners first reported a position in ARDX in Q2 2024 and held it in 7 quarters. The position peaked at $3.35M in Q2 2024. 239 funds tracked by Wall St. Rank hold ARDX as of Q1 2026.

  • Palisades Investment Partners reported no remaining Ardelyx position as of Q1 2026 after selling out during the quarter.
  • Palisades Investment Partners sold 10,147 Ardelyx shares in Q1 2026, an estimated $59.2K.
  • Palisades Investment Partners first reported a position in Ardelyx in Q2 2024 and held it in 7 quarters.
  • Palisades Investment Partners's Ardelyx position peaked at $3.35M in Q2 2024.
  • 239 funds tracked by Wall St. Rank held Ardelyx as of Q1 2026.

Based on Palisades Investment Partners's 13F filing for Q1 2026, filed 30 Apr 2026.